Journals / Akademik Acil Tıp Dergisi / 2009 / Cilt: 8 - Sayı: 2

Emergency approach in HELLP syndrome

HELLP sendromunda acil yaklaşım

Pages
9–12
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The only specific therapy in HELLP syndrome is induction of delivery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:HELLP syndrome (haemolysis, elevated liver enzymes, low platelet count) is a multisystemic disorder that has a poor prognosis and occurring usually in older multiparous women in the third trimester of pregnancy due to a generalized microangiopathy.
📊
Key Findings & Data:If patient has complications such as hepatic rupture, cerebral hemorrhage and disseminated intravascular coagulation (DIC), materno-fetal mortality is high.
💡
Conclusion & Impact:The only specific therapy in HELLP syndrome is induction of delivery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

HELLP syndrome (haemolysis, elevated liver enzymes, low platelet count) is a multisystemic disorder that has a poor prognosis and occurring usually in older multiparous women in the third trimester of pregnancy due to a generalized microangiopathy. If patient has complications such as hepatic rupture, cerebral hemorrhage and disseminated intravascular coagulation (DIC), materno-fetal mortality is high. Severe thrombocytopenia worsens prognosis. The early recognition of HELLP syndrome and the rapid initiation of therapy are required for the improvement of materno-fetal prognosis. The only specific therapy in HELLP syndrome is induction of delivery.

Özet

HELLP sendromu (Hemoliz, karaciğer enzimlerinde yükselme ve plateletlerde azalma), yaygın mikroanjiopatilere bağlı olarak genellikle multipar bayanların üçüncü trimestirinde ortaya çıkan kötü prognozlu multisistemik bir hastalıktır. Eğer hastada, karaciğer rüptürü, beyin kanaması ve yaygın damar içi pıhtılaşması (DİC) varsa, anne-bebek mortalitesi yüksektir. Ciddi trombositopeni prognozu kötüleştirir. HELLP tablosunun erken tanınması ve tedavinin hızlı başlanması, anne-bebek prognozunun düzeltilmesi için gereklidir. HELLP tablosunun özellikli tedavisi, doğum eyleminin gerçekleştirilmesidir.

🔖

Cite This Article

EVSEN, M. S., TEKBAŞ, G., BAŞTÜRK, M., KAPAN, M., TOKGÖZ, O., SUYUÇOK, E., AL, B. (2022). Emergency approach in HELLP syndrome. Akademik Acil Tıp Dergisi, Cilt: 8 - Sayı: 2, 9–12. https://ajindex.com/articles/431791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:159-67
  2. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103: 981-991
  3. Sheikh RA, Yasmeen S, Pauly MP, Riegler JL. Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: four cases and a review. J Clin Gastroenterol 1999; 28:323-8
  4. Yagmurdur MC, Agalar F, Daphan CE. Spontaneous hepatic rupture in pregnancy. Eur J Emerg Med. 2000;7:75-6
  5. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse- Wilde H. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol 2003; 188: 473-479
  6. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004; 286: H1389-1393
  7. Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160: 1405-1423
  8. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. QJM 2002; 95: 343-357
  9. Wicke C, Pereira PL, Neeser E, Flesch I, Rodegerdts EA, Becker HD. Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic optionsa unicenter study. Am J Obstet Gynecol 2004; 190: 106-112
  10. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000-1006
  11. Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R. HELLP syndrome - a multisystemic disorder. J Gastrointestin Liver Dis. 2007;16:419-24
  12. Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 2007; 86: 648-651
  13. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22: 203-212
  14. Ch’ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective stu